Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$27,000.00
Molecular Mechanisms Underlying Rare Neurodevelopmental Disorders
EF 2024-25
Résumé
Communication between neurons through the process of neurotransmission is a very complex process. It requires the right proteins to be at the right place, in the right orientation, and at the right time. Interestingly, more and more problems in this process are being linked with neuropsychiatric and neurodevelopmental disease (NDD). Before we can make drugs to help alleviate these conditions, we must first understand the neurotransmission process. My work will aim to understand the complexity of the brain by looking at how proteins interact at the neuronal synapses and their effects on synaptic function. One important group of proteins called the G protein-coupled receptors (GPCRs) are the largest family of neurotransmitter receptors. They play a vital role in brain cell communication. This has made GPCRs promising drug targets, representing 34% of FDA approved drugs. Largely, it was believed only a neurotransmitters would bind the outer part of the GPCRs; however, we recently found that a group of GPCRs can bind and be altered by a synaptic adhesion molecule (SAM). This was a very exciting finding because before this, structural proteins were not thought to have played an active role in modulating neurotransmission. Nevertheless, our understanding of this phenomenon remains incomplete. Importantly, we have now found this SAM has at least two rare genetic variations that cause neurodevelopmental disease in multiple children. I will explore these two pathogenic variants of the adhesion molecule, determine if they can still bind to GPCRs, and if they can alter GPCR function. I hope by learning about this synaptic complex, we can better understand neurotransmission and possibly guide novel therapeutic strategies for patients harbouring these pathogenic variations.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529650
Name
Dhaliwal Simrat K
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Molecular Mechanisms Underlying Rare Neurodevelopmental Disorders
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Elfn1; G-Protein Coupled Receptors (Gpcrs); Metabotropic Glutamate Receptors; Mglur8; Neurodevelopmental Disorders; Pathogenic Variants; Signalling; Synapse; Synaptic Adhesion Molecule; Trans Synaptic
Abstract
Communication between neurons through the process of neurotransmission is a very complex process. It requires the right proteins to be at the right place, in the right orientation, and at the right time. Interestingly, more and more problems in this process are being linked with neuropsychiatric and neurodevelopmental disease (NDD). Before we can make drugs to help alleviate these conditions, we must first understand the neurotransmission process. My work will aim to understand the complexity of the brain by looking at how proteins interact at the neuronal synapses and their effects on synaptic function. One important group of proteins called the G protein-coupled receptors (GPCRs) are the largest family of neurotransmitter receptors. They play a vital role in brain cell communication. This has made GPCRs promising drug targets, representing 34% of FDA approved drugs. Largely, it was believed only a neurotransmitters would bind the outer part of the GPCRs; however, we recently found that a group of GPCRs can bind and be altered by a synaptic adhesion molecule (SAM). This was a very exciting finding because before this, structural proteins were not thought to have played an active role in modulating neurotransmission. Nevertheless, our understanding of this phenomenon remains incomplete. Importantly, we have now found this SAM has at least two rare genetic variations that cause neurodevelopmental disease in multiple children. I will explore these two pathogenic variants of the adhesion molecule, determine if they can still bind to GPCRs, and if they can alter GPCR function. I hope by learning about this synaptic complex, we can better understand neurotransmission and possibly guide novel therapeutic strategies for patients harbouring these pathogenic variations.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dhaliwal, Simrat K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~